Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday

  • Morgan Stanley cut the price target for ArcBest Corporation ARCB from $136 to $125. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. ArcBest shares fell 3.3% to close at $95.42 on Wednesday.
  • Truist Securities increased the price target for Owens Corning OC from $105 to $135. Truist Securities analyst Keith Hughes maintained a Hold rating. Owens Corning shares fell 2.2% to close at $128.67 on Wednesday.
  • Goldman Sachs increased the price target for Netflix, Inc. NFLX from $230 to $400. Goldman Sachs analyst Eric Sheridan maintained a Neutral rating. Netflix shares fell 1.2% to $440.56 in pre-market trading.
  • Cantor Fitzgerald cut Regeneron Pharmaceuticals, Inc. REGN price target from $815 to $795. Cantor Fitzgerald analyst Alethia Young maintained a Neutral rating. Regeneron Pharmaceuticals shares fell 0.7% to $713.03 in pre-market trading.
  • JMP Securities boosted Protagonist Therapeutics, Inc. PTGX price target from $28 to $35. JMP Securities analyst Jonathan Wolleben maintained a Market Outperform rating. Protagonist Therapeutics shares fell 1.5% to $23.05 in pre-market trading.
  • Raymond James slashed Comerica Incorporated CMA price target from $57 to $53. Raymond James analyst Michael Rose maintained a Strong Buy rating. Comerica shares fell 0.5% to $43.28 in pre-market trading.
  • Rosenblatt raised CME Group Inc. CME price target from $161 to $169. Rosenblatt analyst Andrew Bond maintained a Sell rating. CME Group shares fell 0.1% to $183.84 in pre-market trading.
  • B of A Securities raised the price target for BorgWarner Inc. BWA from $54 to $67. B of A Securities analyst John Murphy upgraded the stock from Neutral to Buy. BorgWarner shares fell 1.7% to close at $43.18 on Wednesday.
  • Keybanc boosted Meta Platforms, Inc. META price target from $280 to $335. Keybanc analyst Justin Patterson maintained an Overweight rating. Meta shares gained 2.9% to close at $294.37 on Wednesday.
  • Jefferies increased Amedisys, Inc. AMED price target from $98 to $101. Jefferies analyst Brian Tanquilut downgraded the stock from Buy to Hold. Amedisys shares dropped 0.5% to $90.80 in pre-market trading.
  • Citigroup raised D.R. Horton, Inc. DHI price target from $124 to $140. Citigroup analyst Anthony Pettinari maintained a Buy rating. D.R. Horton shares fell 0.8% to $118.30 in pre-market trading.

 

Check This Out: Alphabet, Palo Alto Networks And 2 Other Stocks Insiders Are Selling

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!